Skip to main content
NCBI home page
Biochemical Journal logoLink to Biochemical Journal
. 2002 Jun 15;364(Pt 3):649–657. doi: 10.1042/BJ20011191

HIV-1 Tat-associated RNA polymerase C-terminal domain kinase, CDK2, phosphorylates CDK7 and stimulates Tat-mediated transcription.

Sergei Nekhai 1, Meisheng Zhou 1, Anne Fernandez 1, William S Lane 1, Ned J C Lamb 1, John Brady 1, Ajit Kumar 1
PMCID: PMC1222613  PMID: 12049628

Abstract

HIV-1 gene expression is regulated by a viral transactivator protein (Tat) which induces transcriptional elongation of HIV-1 long tandem repeat (LTR). This induction requires hyperphosphorylation of the C-terminal domain (CTD) repeats of RNA polymerase II (Pol II). To achieve CTD hyperphosphorylation, Tat stimulates CTD kinases associated with general transcription factors of the promoter complex, specifically TFIIH-associated CDK7 and positive transcription factor b-associated CDK9 (cyclin-dependent kinase 9). Other studies indicate that Tat may bind an additional CTD kinase that regulates the target-specific phosphorylation of RNA Pol II CTD. We previously reported that Tat-associated T-cell-derived kinase (TTK), purified from human primary T-cells, stimulates Tat-dependent transcription of HIV-1 LTR in vivo [Nekhai, Shukla, Fernandez, Kumar and Lamb (2000) Virology 266, 246-256]. In the work presented here, we characterized the components of TTK by biochemical fractionation and the function of TTK in transcription assays in vitro. TTK uniquely co-purified with CDK2 and not with either CDK9 or CDK7. Tat induced the TTK-associated CDK2 kinase to phosphorylate CTD, specifically at Ser-2 residues. The TTK fraction restored Tat-mediated transcription activation of HIV-1 LTR in a HeLa nuclear extract immunodepleted of CDK9, but not in the HeLa nuclear extract double-depleted of CDK9 and CDK7. Direct microinjection of the TTK fraction augmented Tat transactivation of HIV-1 LTR in human primary HS68 fibroblasts. The results argue that TTK-associated CDK2 may function to maintain target-specific phosphorylation of RNA Pol II that is essential for Tat transactivation of HIV-1 promoter. They are also consistent with the observed cell-cycle-specific induction of viral gene transactivation.

Full Text

The Full Text of this article is available as a PDF (311.4 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adams M., Sharmeen L., Kimpton J., Romeo J. M., Garcia J. V., Peterlin B. M., Groudine M., Emerman M. Cellular latency in human immunodeficiency virus-infected individuals with high CD4 levels can be detected by the presence of promoter-proximal transcripts. Proc Natl Acad Sci U S A. 1994 Apr 26;91(9):3862–3866. doi: 10.1073/pnas.91.9.3862. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Antoni B. A., Stein S. B., Rabson A. B. Regulation of human immunodeficiency virus infection: implications for pathogenesis. Adv Virus Res. 1994;43:53–145. doi: 10.1016/s0065-3527(08)60047-0. [DOI] [PubMed] [Google Scholar]
  3. Boris-Lawrie K. A., Brady J. N., Kumar A. Sequences within the R region of the long terminal repeat activate basal transcription from the HIV-1 promoter. Gene Expr. 1992;2(3):215–230. [PMC free article] [PubMed] [Google Scholar]
  4. Chittum H. S., Lane W. S., Carlson B. A., Roller P. P., Lung F. D., Lee B. J., Hatfield D. L. Rabbit beta-globin is extended beyond its UGA stop codon by multiple suppressions and translational reading gaps. Biochemistry. 1998 Aug 4;37(31):10866–10870. doi: 10.1021/bi981042r. [DOI] [PubMed] [Google Scholar]
  5. Chodosh L. A., Fire A., Samuels M., Sharp P. A. 5,6-Dichloro-1-beta-D-ribofuranosylbenzimidazole inhibits transcription elongation by RNA polymerase II in vitro. J Biol Chem. 1989 Feb 5;264(4):2250–2257. [PubMed] [Google Scholar]
  6. Cisek L. J., Corden J. L. Purification of protein kinases that phosphorylate the repetitive carboxyl-terminal domain of eukaryotic RNA polymerase II. Methods Enzymol. 1991;200:301–325. doi: 10.1016/0076-6879(91)00148-p. [DOI] [PubMed] [Google Scholar]
  7. Clark E., Santiago F., Deng L., Chong S., de La Fuente C., Wang L., Fu P., Stein D., Denny T., Lanka V. Loss of G(1)/S checkpoint in human immunodeficiency virus type 1-infected cells is associated with a lack of cyclin-dependent kinase inhibitor p21/Waf1. J Virol. 2000 Jun;74(11):5040–5052. doi: 10.1128/jvi.74.11.5040-5052.2000. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Cullen B. R. HIV-1 auxiliary proteins: making connections in a dying cell. Cell. 1998 May 29;93(5):685–692. doi: 10.1016/s0092-8674(00)81431-2. [DOI] [PubMed] [Google Scholar]
  9. Feng S., Holland E. C. HIV-1 tat trans-activation requires the loop sequence within tar. Nature. 1988 Jul 14;334(6178):165–167. doi: 10.1038/334165a0. [DOI] [PubMed] [Google Scholar]
  10. Fisher R. P., Jin P., Chamberlin H. M., Morgan D. O. Alternative mechanisms of CAK assembly require an assembly factor or an activating kinase. Cell. 1995 Oct 6;83(1):47–57. doi: 10.1016/0092-8674(95)90233-3. [DOI] [PubMed] [Google Scholar]
  11. Garber M. E., Mayall T. P., Suess E. M., Meisenhelder J., Thompson N. E., Jones K. A. CDK9 autophosphorylation regulates high-affinity binding of the human immunodeficiency virus type 1 tat-P-TEFb complex to TAR RNA. Mol Cell Biol. 2000 Sep;20(18):6958–6969. doi: 10.1128/mcb.20.18.6958-6969.2000. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Garber M. E., Wei P., KewalRamani V. N., Mayall T. P., Herrmann C. H., Rice A. P., Littman D. R., Jones K. A. The interaction between HIV-1 Tat and human cyclin T1 requires zinc and a critical cysteine residue that is not conserved in the murine CycT1 protein. Genes Dev. 1998 Nov 15;12(22):3512–3527. doi: 10.1101/gad.12.22.3512. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Graña X., De Luca A., Sang N., Fu Y., Claudio P. P., Rosenblatt J., Morgan D. O., Giordano A. PITALRE, a nuclear CDC2-related protein kinase that phosphorylates the retinoblastoma protein in vitro. Proc Natl Acad Sci U S A. 1994 Apr 26;91(9):3834–3838. doi: 10.1073/pnas.91.9.3834. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Herrmann C. H., Rice A. P. Lentivirus Tat proteins specifically associate with a cellular protein kinase, TAK, that hyperphosphorylates the carboxyl-terminal domain of the large subunit of RNA polymerase II: candidate for a Tat cofactor. J Virol. 1995 Mar;69(3):1612–1620. doi: 10.1128/jvi.69.3.1612-1620.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Ivanov D., Kwak Y. T., Nee E., Guo J., García-Martínez L. F., Gaynor R. B. Cyclin T1 domains involved in complex formation with Tat and TAR RNA are critical for tat-activation. J Mol Biol. 1999 Apr 23;288(1):41–56. doi: 10.1006/jmbi.1999.2663. [DOI] [PubMed] [Google Scholar]
  16. Jeang K. T. Tat, Tat-associated kinase, and transcription. J Biomed Sci. 1998;5(1):24–27. doi: 10.1007/BF02253352. [DOI] [PubMed] [Google Scholar]
  17. Karn J. Tackling Tat. J Mol Biol. 1999 Oct 22;293(2):235–254. doi: 10.1006/jmbi.1999.3060. [DOI] [PubMed] [Google Scholar]
  18. Kashanchi F., Agbottah E. T., Pise-Masison C. A., Mahieux R., Duvall J., Kumar A., Brady J. N. Cell cycle-regulated transcription by the human immunodeficiency virus type 1 Tat transactivator. J Virol. 2000 Jan;74(2):652–660. doi: 10.1128/jvi.74.2.652-660.2000. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Kimpton J., Emerman M. Detection of replication-competent and pseudotyped human immunodeficiency virus with a sensitive cell line on the basis of activation of an integrated beta-galactosidase gene. J Virol. 1992 Apr;66(4):2232–2239. doi: 10.1128/jvi.66.4.2232-2239.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Laspia M. F., Rice A. P., Mathews M. B. HIV-1 Tat protein increases transcriptional initiation and stabilizes elongation. Cell. 1989 Oct 20;59(2):283–292. doi: 10.1016/0092-8674(89)90290-0. [DOI] [PubMed] [Google Scholar]
  21. Marshall N. F., Price D. H. Purification of P-TEFb, a transcription factor required for the transition into productive elongation. J Biol Chem. 1995 May 26;270(21):12335–12338. doi: 10.1074/jbc.270.21.12335. [DOI] [PubMed] [Google Scholar]
  22. Martinez A. M., Afshar M., Martin F., Cavadore J. C., Labbé J. C., Dorée M. Dual phosphorylation of the T-loop in cdk7: its role in controlling cyclin H binding and CAK activity. EMBO J. 1997 Jan 15;16(2):343–354. doi: 10.1093/emboj/16.2.343. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Nekhai S., Shukla R. R., Fernandez A., Kumar A., Lamb N. J. Cell cycle-dependent stimulation of the HIV-1 promoter by Tat-associated CAK activator. Virology. 2000 Jan 20;266(2):246–256. doi: 10.1006/viro.1999.0035. [DOI] [PubMed] [Google Scholar]
  24. Nekhai S., Shukla R. R., Kumar A. A human primary T-lymphocyte-derived human immunodeficiency virus type 1 Tat-associated kinase phosphorylates the C-terminal domain of RNA polymerase II and induces CAK activity. J Virol. 1997 Oct;71(10):7436–7441. doi: 10.1128/jvi.71.10.7436-7441.1997. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Peterson S. R., Dvir A., Anderson C. W., Dynan W. S. DNA binding provides a signal for phosphorylation of the RNA polymerase II heptapeptide repeats. Genes Dev. 1992 Mar;6(3):426–438. doi: 10.1101/gad.6.3.426. [DOI] [PubMed] [Google Scholar]
  26. Taube R., Fujinaga K., Wimmer J., Barboric M., Peterlin B. M. Tat transactivation: a model for the regulation of eukaryotic transcriptional elongation. Virology. 1999 Nov 25;264(2):245–253. doi: 10.1006/viro.1999.9944. [DOI] [PubMed] [Google Scholar]
  27. Vulsteke V., Beullens M., Waelkens E., Stalmans W., Bollen M. Properties and phosphorylation sites of baculovirus-expressed nuclear inhibitor of protein phosphatase-1 (NIPP-1). J Biol Chem. 1997 Dec 26;272(52):32972–32978. doi: 10.1074/jbc.272.52.32972. [DOI] [PubMed] [Google Scholar]
  28. Wei P., Garber M. E., Fang S. M., Fischer W. H., Jones K. A. A novel CDK9-associated C-type cyclin interacts directly with HIV-1 Tat and mediates its high-affinity, loop-specific binding to TAR RNA. Cell. 1998 Feb 20;92(4):451–462. doi: 10.1016/s0092-8674(00)80939-3. [DOI] [PubMed] [Google Scholar]
  29. Yang X., Gold M. O., Tang D. N., Lewis D. E., Aguilar-Cordova E., Rice A. P., Herrmann C. H. TAK, an HIV Tat-associated kinase, is a member of the cyclin-dependent family of protein kinases and is induced by activation of peripheral blood lymphocytes and differentiation of promonocytic cell lines. Proc Natl Acad Sci U S A. 1997 Nov 11;94(23):12331–12336. doi: 10.1073/pnas.94.23.12331. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Yankulov K., Yamashita K., Roy R., Egly J. M., Bentley D. L. The transcriptional elongation inhibitor 5,6-dichloro-1-beta-D-ribofuranosylbenzimidazole inhibits transcription factor IIH-associated protein kinase. J Biol Chem. 1995 Oct 13;270(41):23922–23925. doi: 10.1074/jbc.270.41.23922. [DOI] [PubMed] [Google Scholar]
  31. Yates J. R., 3rd, McCormack A. L., Eng J. Mining genomes with MS. Anal Chem. 1996 Sep 1;68(17):534A–540A. doi: 10.1021/ac962050l. [DOI] [PubMed] [Google Scholar]
  32. Zhou M., Halanski M. A., Radonovich M. F., Kashanchi F., Peng J., Price D. H., Brady J. N. Tat modifies the activity of CDK9 to phosphorylate serine 5 of the RNA polymerase II carboxyl-terminal domain during human immunodeficiency virus type 1 transcription. Mol Cell Biol. 2000 Jul;20(14):5077–5086. doi: 10.1128/mcb.20.14.5077-5086.2000. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Zhu Y., Pe'ery T., Peng J., Ramanathan Y., Marshall N., Marshall T., Amendt B., Mathews M. B., Price D. H. Transcription elongation factor P-TEFb is required for HIV-1 tat transactivation in vitro. Genes Dev. 1997 Oct 15;11(20):2622–2632. doi: 10.1101/gad.11.20.2622. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Biochemical Journal are provided here courtesy of The Biochemical Society

RESOURCES